Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation

Journal of Cellular Physiology

Volumn 215, Issue 2, 2008, Pages 410-421

  Vial, Cecilia ^a   Zúñiga, Lidia Miriam ^a   Cabello Verrugio, Claudio ^a   Cañón, Pablo ^a   Fadic, Ricardo ^b   Brandan, Enrique ^a,b  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; DESMIN; FIBRONECTIN; LYSOPHOSPHATIDIC ACID; MYOGENIN; MYOSIN; TRANSFORMING GROWTH FACTOR BETA; IMMEDIATE EARLY PROTEIN; LYSOPHOSPHOLIPID; MYOD PROTEIN; RECOMBINANT PROTEIN; SCLEROPROTEIN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOSKELETON; EXTRACELLULAR MATRIX; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA ISOLATION; SKELETAL MUSCLE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL DEDIFFERENTIATION; CELL LINE; CELL NUCLEUS; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CYTOSKELETON; DESMIN; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSOPHOSPHOLIPIDS; MICE; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS; MYOD PROTEIN; MYOGENIN; MYOSINS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 40949152810     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21324     Document Type: Article

References (70)

1. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. 2000. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 275:15220-15225.
2. Abreu JG, Ketpura NI, Reversade B, De Roberts EM. 2002. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4:599-604.
3. Alvarez K, Fadic R, Brandan E. 2002. Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy. J Cell Biochem 85:703-713.
4. Bernasconi P, Di Blasi C, Mora M, Morandi L, Galbiati S, Confalonieri P, Cornelio F, Mantegazza R. 1999. Transforminggrowth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul Disord 9:28-33.
5. Bischoff R. 1986. Proliferation of muscle satellite cells on intact myofibers in culture. Dev Biol 115:129-139.
6. Bowe M, Mendis D, Fallon J. 2000. The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J Cell Biol 148:801-810.
7. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. 1991. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114:1285-1294.
8. Brandan E, Inestrosa NC. 1984. Binding of the asymmetric forms of acetylcholinesterase to heparin. Biochem J 221:415-422.
9. Brandan E, Fuentes ME, Andrade W. 1992. Decorin, a chondroitin/dermatan sulfate proteoglycan is under neural control in rat skeletal muscle. J Neurosci Res 32:51-59.
10. Brigstock DR. 2003. The CCN family: A new stimulus package. J Endocrinol 178:169-175.
11. Caceres S, Cuellar C, Casar JC, Garrido J, Schaefer L, Kresse H, Brandan E. 2000. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Eur J Cell Biol 79:173-181.
12. Caldwell CJ, Mattey DL, Weller RO. 1990. Role of the basement membrane in the regeneration of skeletal muscle. Neuropathol Appl Neurobiol 16:225-238.
13. Casar JC, Cabello-Verrugio C, Olguin H, Aldunate R, Inestrosa NC, Brandan E. 2004. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: Requirement of syndecan-3 for successful fiber formation. J Cell Sci 117:73-84.
14. Chen S, Zhang Q, Wu X, Schultz PG, Ding S. 2004. Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126:410-411.
15. Chen X, Mao Z, Liu S, Liu H, Wang X, Wu H, Wu Y, Zhao T, Fan W, Li Y, Yew DT, Kindler PM, Li L, He Q, Qian L, Fan M. 2005. Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. Mol Biol Cell 16:3140-3151.
16. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
17. Crean JK, Furlong F, Mitchell D, McArdle E, Godson C, Martin F. 2006. Connective tissue growth factor/CCN2 stimulates actin disassembly through Akt/protein kinase B-mediated phosphorylation and cytoplasmic translocation of p27(Kip-1). FASEB J 20:1712-1714.
18. Denton CP, Abraham DJ. 2001. Transforming growth factor-beta and connective tissue growth factor: Key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 13:505-511.
19. Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E. 2006. Extracellular proteoglycans modifies TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol 25:332-341.
20. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. 1999. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by cAMP. FASEB J 13:1774-1786.
21. Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. 1993. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291:677-680.
22. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR. 1994. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: Greater mitogenic actions of IGF-I delay differentiation. J Cell Physiol 161:277-284.
23. Fadic R, Mezzano V, Alvarez K, Cabrera D, Holmgren J, Brandan E. 2006. Increase in decorin and biglycan in Duchenne Muscular Dystrophy: Role of fibroblasts as cell source of these proteoglycans in the disease. J Cell Mol Med 10:758-769.
24. Florini JR, Roberts AB, Ewton DZ, Falen SL, Flanders KC, Sporn MB. 1986. Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J Biol Chem 261:16509-16513.
25. Frazier K, Williams S. Kothapalli D, Klapper H, Grotendorst GR. 1996. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107:404-411.
26. Gao R, Brigstock DR. 2004. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279:8848-8855.
27. Gao R, Ball DK, Perbal B, Brigstock DR. 2004. Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol 40:431-438.
28. Gerrard JM, Robinson P. 1989. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta 1001:282-285.
29. Goppelt-Struebe M, Fickel S, Reiser CO. 2000. The platelet-derived- growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells. Biochem J 345:217-224.
30. Grotendorst GR. 1997. Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8:171-179.
31. Hartel JV, Granchelli JA, Hudecki MS, Pollina CM, Gosselin LE. 2001. Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice. Muscle Nerve 24:428-432.
32. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A. 2001. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276:10594-10601.
33. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR, Takehara K. 1995. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 105:280-284.
34. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K. 1996. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729-733.
35. Ihn H. 2002. Pathogenesis of fibrosis: Role of TGF-beta and CTGF. Curr Opin Rheumatol 14:681-685.
36. Inagaki Y, Truter S, Tanaka S, Di Liberto M, Ramirez F. 1995. Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha 2(I) collagen gene transcription. J Biol Chem 270:3353-3358.
37. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R. 1998. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861.
38. Jean-Baptiste G, Yang Z, Khoury C, Greenwood MT. 2005. Lysophosphatidic acid mediates pleiotropic responses in skeletal muscle cells. Biochem Biophys Res Commun 335:1155-1162.
39. Jones MC, Caswell PT, Norman JC. 2006. Endocytic recycling pathways: Emerging regulators of cell migration. Curr Opin Cell Biol 18:549-557.
40. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, Lau LF. 1997. Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism, and localization during development. Exp Cell Res 233:63-77.
41. Larrain J, Cizmeci-Smith G, Troncoso V, Stahl RC, Carey DJ, Brandan E. 1997. Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid. J Biol Chem 272:18418-18424.
42. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, Friedman M. 1998. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol 275:L365-L371.
43. Leask A, Abraham DJ. 2004. TGF-beta signaling and the fibrotic response. FASEB J 18:816-827.
44. Li H, Capetanaki Y. 1993. Regulation of the mouse desmin gene: Transactivated by MyoD, myogenin, MRF4 and Myf5. Nucleic Acids Res 21:335-343.
45. Li H, Capetanaki Y. 1994. An E box in the desmin promoter cooperates with the E box and MEF-2 sites of a distal enhancer to direct muscle-specific transcription. EMBO J 13:3580-3589.
46. Li Y, Huard J. 2002. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161:895-907.
47. Lopez-Casillas F, Riquelme C, Perez-Kato Y, Ponce-Castaneda MV, Osses N, Esparza-Lopez J, Gonzalez-Nunez G, Cabello-Verrugio C, Mendoza V, Troncoso V, Brandan E. 2003. Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta. J Biol Chem 278:382-390.
48. Massague J, Cheifetz S, Endo T, Nadal-Ginard B. 1986. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA 83:8206-8210.
49. Moolenaar WH, 1994. LPA: A novel lipid mediator with diverse biological actions. Trends Cell Biol 4:213-219.
50. Moolenaar WH, van Meeteren LA, Giepmans BN. 2004. The ins and outs of lysophosphatidic acid signaling. Bioessays 26:870-881.
51. Muehlich S, Schneider N, Hinkmann F, Garlichs CD, Goppelt-Struebe M. 2004. Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. Atherosclerosis 175:261-268.
52. Murakami N, McLennan IS, Nonaka I, Koishi K, Baker C, Hammond-Tooke G. 1999. Transforming growth factor-beta2 is elevated in skeletal muscle disorders. Muscle Nerve 22:889-898.
53. Odelberg SJ, Kollhoff A, Keating MT. 2000. Dedifferentiation of mammalian myotubes induced by msx1. Cell 103:1099-1109.
54. Osses N, Brandan E. 2002. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am J Physiol Cell Physiol 282:C383-C394.
55. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V, Gauthier JM, Ba N, Sobesky R, Ratziu V, Bedossa P. 1999. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30:968-976.
56. Passerini L, Bernasconi P, Baggi F, Confalonieri P, Cozzi F, Cornelio F, Mantegazza R. 2002. Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy. Neuromuscul Disord 12:828-835.
57. Paulin D, Li Z. 2004. Desmin: A major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res 301:1-7.
58. Perbal B. 2004. CCN proteins: Multifunctional signalling regulators. Lancet 363:62-64.
59. Porter JD, Merriam AP, Leahy P, Gong B, Khanna S. 2003. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet 12:1813-1821.
60. Rampoldi E, Meola G, Conti A, Velicogna M, Larizza L. 1986. A comparative analysis of collagen III, IV, laminin and fibronectin in Duchenne muscular dystrophy biopsies and cell cultures. Eur J Cell Biol 42:27-34.
61. Riquelme C, Larrain J, Schonherr E, Henriquez JP, Kresse H, Brandan E. 2001. Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation. J Biol Chem 276:3589-3596.
62. Roberts AB, McCune BK, Sporn MB. 1992. TGF-beta: Regulation of extracellular matrix. Kidney Int 41:557-559.
63. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. 1993. MyoD or Myf-S is required for the formation of skeletal muscle. Cell 75:1351-1359.
64. Sabourin LA, Rudnicki MA. 2000. The molecular regulation of myogenesis. Clin Genet 57:16-25.
65. Salvadori C, Peters IR, Day MJ, Engvall E, Shelton GD. 2005. Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy. Muscle Nerve 31:192-198.
66. Simeon A, Monier F, Emonard H, Wegrowski Y, Bellon G, Monboisse J, Gillery P, Hornebeck W, Maquart F. 1999. Fibroblast-cytokine-extracellular matrix interactions in wound repair. Curr Top Pathol 93:95-101.
67. Tsai RY, Kittappa R, McKay RD. 2002. Plasticity, niches, and the use of stem cells. Dev Cell 2:707-712.
68. Ugarte G, Brandan E. 2006. Transforming growth factor beta (TGF-beta) signaling is regulated by electrical activity in skeletal muscle cells. TGF-beta type I receptor is transcriptionally regulated by myotube excitability. J Biol Chem 281:18473-18481.
69. van de Klundert FA, Jansen HJ, Bloemendal H. 1994. A proximal promoter element in the hamster desmin upstream regulatory region is responsible for activation by myogenic determination factors. J Biol Chem 269:220-225.
70. Yosimichi G, Kubota S, Nishida T, Kondo S, Yanagita T, Nakao K, Takano-Yamamoto T, Takigawa M. 2006. Roles of PKC, PI3K and JNK in multiple transduction of CCN2/CTGF signals in chondrocytes. Bone 38:853-863.